What You Should Know: - Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B. - The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Seven Bridges, USP, Google Cloud to Build A Brazilian Reference Genome
What You Should Know: - Seven Bridges, a bioinformatics ecosystem provider, announced it is collaborating with the University of São Paulo (USP) and Google Cloud, as well as the Associação Genomas Brasil (Brazil Genome Association), to assist the DNA do Brasil (DNABr) project in building a reference genome that represents the genetic diversity of the Brazilian population. - The joint effort will advance unbiased precision medicine for underrepresented populations in Brazil through the
Read More
PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s Disease
What You Should Know: - Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study. - The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms. Challenges Diagnosing Parkinson’s
Read More
THREAD Acquires Clinical Trial Recruitment Solution CureClick
What You Should Know: - THREAD, a technology and consulting service provider enabling electronic clinical outcome assessments and decentralized clinical trials has acquired CureClick, which offers the world’s first proprietary crowdsourcing platform designed to accelerate awareness and participation in clinical research. This acquisition follows THREAD’s recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry’s leading
Read More
Salignostics Raises $8M for Rapid Saliva-Based Test Kits That Detect Pregnancy, COVID-19, Cardiac Risk, and Malaria
What You Should Know: - Israeli startup Salignostics, the developer and provider of rapid saliva-based tests for early pregnancy detection, as well as COVID-19, cardiac risk, malaria, and other diseases, has closed an $8 million Series A funding round from private investors headed by angel investor Avigdor Orlinsky. - The company has raised $16M to date to support development, commercialization, and marketing efforts for the tests in Israel and overseas. It will also support the launch of
Read More
DaVita to Invest $15M in Biopharma Company Rockwell Medical
What You Should Know: - Rockwell Medical, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management expands its partnership with kidney care leader DaVita Inc. Rockwell Medical has been working to revise certain terms of its supply contracts with customers in an effort to stabilize its concentrates business. - The amended supply agreement is designed to enable Rockwell Medical's concentrates business the potential to operate
Read More
Komodo & Datavant Partner to Unlock Real World Data Across Healthcare
What You Should Know: - Today, Komodo Health and Datavant are expanding their partnership to make it even easier for companies to bring together disparate datasets and unlock deeper insights to speed innovation and improve patient outcomes. Together, the companies are helping customers gain more value than ever before from their proprietary or third-party data by linking it with Komodo’s longitudinal patient journey data and advanced analytics platform – all without compromising patient
Read More
AmerisourceBergen Launches $150M Corporate Venture Fund
What You Should Know: - AmerisourceBergen, a global healthcare solutions company, announced the establishment of AB Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with emerging healthcare startup companies working to transform healthcare for people and animals globally. - AB Health Ventures will build on AmerisourceBergen’s ongoing commitment to delivering innovation for its customers. AB Health Ventures Investment Thesis AB Health
Read More
PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development
What You Should Know: - PathAI and GSK announced a multi-year strategic artificial intelligence (AI) partnership today with a focus on accelerating research and- building drug development programs in oncology and non-alcoholic steatohepatitis (NASH). - As part of the partnership, GSK will leverage both PathAI’s expertise and models to advance GSK’s proprietary AI models and focus on designing better models to deliver improved treatment options for patients with cancer
Read More
C2i Genomics Brings Distributed Cancer Monitoring to Cancer Centers Across Europe
What You Should Know: - C2i Genomics, a cancer intelligence company launches its C2inform minimal residual disease (MRD) test across Europe, after obtaining CE-IVD marking in the EU, UK and Switzerland. The company also announced the completion of several clinical trials across the globe, including leading cancer centers in Europe, U.S. and Singapore. - The new clinical data will be presented at the 2022 American Association for Cancer Research (AACR) annual meeting in New Orleans,
Read More
